HeartRisk combines insights from HIPAA-compliant anonymized and aggregated clinical cardiovascular data obtained through
This expansion extends the reach of its proprietary data intelligence platform to correctional facilities, risk-bearing providers engaged in value-based contracts, and broker and benefits consultants. The move marks a strategic leap in addressing the financial and security challenges, such as those associated with transporting inmates in correctional facilities, of scaling access to cardiovascular testing across diverse sectors.
'By expanding our HeartRisk platform, we're not just innovating within traditional healthcare sectors but breaking new ground in diverse markets. From correctional facilities to value-based care providers and workplace wellness programs to brokerage and benefits consultants, our precision cardiovascular solutions provide actionable insights. By coupling data intelligence to evidence-based and scalable clinical tests, we're enabling these healthcare stakeholders and their organizations to make data-driven decisions to address rising healthcare costs and implement more effective chronic disease management. We're not just advancing precision medicine; we're ensuring those insights can be leveraged at the population level for multiple sectors,' shared
Risk-Bearing Providers and Value-Based Care
Risk-bearing providers, such as
Empowering Workplace Wellness & Financial Health
The expanded offering equips employers with unparalleled insights into workforce health trends related not just to cardiovascular risks but also encapsulating broader wellness indicators crucial for business resilience and productivity. By integrating predictive analytics around CVD within comprehensive workplace wellness initiatives, employers can reduce healthcare costs significantly while fostering an invigorated workplace culture centered on health mindfulness.
Enabling Precision-Driven Decision-Making for Employer Clients
Brokerage and benefits entities play a pivotal role in aligning coverage plans that articulate both value and efficacy against chronic conditions like CVD, which are substantial cost centers for their clientele. The enhanced functionalities within the HeartRisk platform allow these entities to offer meticulous plan designs optimized by granular cumulative data insights, thus ensuring impactful investments in healthcare portfolios. This includes being able to guide employer clients on stop-loss insurance decisions, benefits allocations, and premium and escrow limits using more real-time aggregated employer CVD risk intelligence data based on clinical tests for a prospective analysis rather than a retrospective analysis.
Tackling Healthcare Challenges Behind Bars: A Constitutional Requirement
Cardiovascular disease is a leading cause of death among incarcerated individuals. The incarcerated population exhibits higher rates of cardiovascular risk factors, such as smoking and hypertension, compared to the general population. Correctional facilities have a constitutional obligation to care for the health of incarcerated individuals. This includes the provision of medical and mental health care, which is complicated by the high prevalence of chronic diseases, mental health issues, and substance use disorders among the incarcerated population.
The complexity of providing care in correctional facilities is exacerbated by resource constraints and the difficulty of providing specialized care for heart disease without transportation. The costs and security risks associated with transporting inmates into healthcare settings and facilities are staggering. Annually, more than
Impact on Healthcare Costs and Chronic Disease Management
The expansion of the HeartRisk platform is aligned with the broader trend in healthcare towards prevention and value-based care. Preventive measures are not only lifesaving but also economically beneficial, with an estimated return of
About
Forward-Looking Statements
Certain statements and information included in this press release constitute 'forward-looking statements' within the meaning of the Private Securities Litigation Act of 1995. When used in this press release, the words or phrases 'will,' 'will likely result,' 'expected to,' 'will continue,' 'anticipated,' 'estimate,' 'projected,' 'intend,' 'goal,' or similar expressions are intended to identify 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company. Such uncertainties and risks include but are not limited to, our ability to successfully execute our growth strategy, changes in laws or regulations, economic conditions, dependence on management, dilution to stockholders, lack of capital, the effects of rapid growth upon the Company and the ability of management to effectively respond to the growth and demand for products and services of the Company, newly developing technologies, the Company's ability to compete, regulatory matters, protection of technology, the effects of competition and the ability of the Company to obtain future financing. An extensive list of factors that can affect future results are discussed in the Current Report on Form 10-K for the period ended
Contact:
Tel: 855-226-9991
Email: investors@cardiodiagnosticsinc.com
Khullani Abdullahi
Tel: 855-226-9991
Email: pr@cardiodiagnosticsinc.com
(C) 2024 Electronic News Publishing, source